Literature DB >> 18550666

Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity.

Xiaoyong Bao1, Deepthi Kolli, Tianshuang Liu, Yichu Shan, Roberto P Garofalo, Antonella Casola.   

Abstract

Human metapneumovirus, a leading cause of respiratory tract infections in infants, encodes a small hydrophobic (SH) protein of unknown function. In this study, we showed that infection of airway epithelial cells or mice with recombinant human metapneumovirus lacking SH expression (rhMPV-DeltaSH) enhanced secretion of proinflammatory mediators, including interleukin 6 (IL-6) and IL-8, encoded by two NF-kB-dependent genes, compared to infection with wild-type rhMPV. RhMPV-DeltaSH infection resulted in enhanced NF-kB-dependent gene transcription and in increased levels of phosphorylated and acetylated NF-kB without affecting its nuclear translocation, identifying a possible novel mechanism by which paramyxovirus SH proteins modulate NF-kB activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550666      PMCID: PMC2519579          DOI: 10.1128/JVI.02584-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.

Authors:  M Karin; M Delhase
Journal:  Semin Immunol       Date:  2000-02       Impact factor: 11.130

2.  Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.

Authors:  D Wang; S D Westerheide; J L Hanson; A S Baldwin
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

3.  Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression.

Authors:  A Casola; R P Garofalo; M Jamaluddin; S Vlahopoulos; A R Brasier
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups.

Authors:  Guy Boivin; Yacine Abed; Gilles Pelletier; Louisette Ruel; Danielle Moisan; Stéphanie Côté; Teresa C T Peret; Dean D Erdman; Larry J Anderson
Journal:  J Infect Dis       Date:  2002-10-08       Impact factor: 5.226

5.  Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.

Authors:  A Casola; R P Garofalo; H Haeberle; T F Elliott; R Lin; M Jamaluddin; A R Brasier
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Analysis of the genomic sequence of a human metapneumovirus.

Authors:  Bernadette G van den Hoogen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

7.  Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation.

Authors:  A Casola; N Burger; T Liu; M Jamaluddin; A R Brasier; R P Garofalo
Journal:  J Biol Chem       Date:  2001-03-20       Impact factor: 5.157

8.  Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation.

Authors:  Antonella Casola; Allyne Henderson; Tianshuang Liu; Roberto P Garofalo; Allan R Brasier
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08-09       Impact factor: 5.464

9.  Adeno-associated virus type 2 Rep78 inhibition of PKA and PRKX: fine mapping and analysis of mechanism.

Authors:  Michael Schmidt; John A Chiorini; Sandra Afione; Robert Kotin
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

10.  Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells.

Authors:  Bing Tian; Yuhong Zhang; Bruce A Luxon; Roberto P Garofalo; Antonella Casola; Mala Sinha; Allan R Brasier
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more
  38 in total

Review 1.  Recent vaccine development for human metapneumovirus.

Authors:  J Ren; T Phan; X Bao
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

Review 2.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

Review 3.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

4.  The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activity.

Authors:  Cyril Masante; Farah El Najjar; Andres Chang; Angela Jones; Carole L Moncman; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

5.  Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activation.

Authors:  Cyril Le Nouën; Philippa Hillyer; Linda G Brock; Christine C Winter; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  Mumps Virus SH Protein Inhibits NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor 1, Interleukin-1 Receptor 1, and Toll-Like Receptor 3 Complexes.

Authors:  Stephanie Franz; Paul Rennert; Maria Woznik; Josephine Grützke; Amy Lüdde; Eva Maria Arriero Pais; Tim Finsterbusch; Henriette Geyer; Annette Mankertz; Nicole Friedrich
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

7.  Human metapneumovirus M2-2 protein inhibits innate cellular signaling by targeting MAVS.

Authors:  Junping Ren; Qingrong Wang; Deepthi Kolli; Deborah J Prusak; Chien-Te K Tseng; Zhijian J Chen; Kui Li; Thomas G Wood; Xiaoyong Bao
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 8.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 9.  Viral miniproteins.

Authors:  Daniel DiMaio
Journal:  Annu Rev Microbiol       Date:  2014-04-10       Impact factor: 15.500

10.  Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.

Authors:  Eun-Jin Choi; Yuping Ren; Yu Chen; Shengxuan Liu; Wenzhe Wu; Junping Ren; Pingyuan Wang; Roberto P Garofalo; Jia Zhou; Xiaoyong Bao
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.